Table 2.
Variables | Overall | Non-COVID era (2019) | COVID era (2020) | p value |
---|---|---|---|---|
Patients | 1226 | 676 (55.1%) | 550 (44.9%) | |
Age (years) | 64.93 ± 15.14 | 64.87 ± 15.7 | 65.00 ± 14.39 | .87 |
Women | 618 (50.4%) | 340 (50.3%) | 278 (50.5%) | .89 |
Number of Procedures | 1496 | 825 (55.15%) | 671 (45.85%) | <.001 |
Ward of provenance (per procedure) | .01 | |||
Emergency department | 181 (12.10%) | 115 (13.94%) | 66 (9.84%) | |
General ward | 1176 (78.61%) | 647 (78.42%) | 529 (78.84%) | |
Outpatients | 111 (7.42%) | 52 (6.30%) | 59 (8.79%) | |
Intensive care units | 28 (1.87%) | 11 (1.33%) | 17 (2.53%) | |
Procedural guidance | .03 | |||
Fluoroscopy | 703 (46.99%) | 367 (44.48%) | 336 (50.07%) | |
US | 251 (16.78%) | 141 (17.09%) | 110 (16.39%) | |
CT | 136 (9.09%) | 87 (10.55%) | 49 (7.30%) | |
US + CT | 8 (0.53%) | 2 (.24%) | 6 (.89%) | |
US + fluoroscopy | 398 (26.60%) | 228 (27.64%) | 170 (25.34%) | |
Bedside procedures | 16 (1.07%) | 12 (1.45%) | 4 (.60%) | .13 |
Type of procedure | .22 | |||
Diagnostic | 248 (18.1%) | 128 (15.5%) | 120 (17.9%) | |
Therapeutic | 1248 (83.42%) | 697 (84.48%) | 551 (82.12%) | |
Body part | .01 | |||
Head | 132 (8.82%) | 65 (7.88%) | 67 (9.99%) | |
Chest | 123 (8.22%) | 81 (9.82%) | 42 (6.26%) | |
Abdomen | 1007 (67.31%) | 549 (66.55%) | 458 (68.26%) | |
Bone | 62 (4.14%) | 27 (3.27%) | 35 (5.22%) | |
Others | 172 (11.50%) | 103 (12.48%) | 69 (10.28%) | |
Urgency of procedure | .18 | |||
Elective | 1019 (68.1%) | 550 (66.7%) | 469 (69.9%) | |
Emergency | 477 (31.9%) | 275 (33.3%) | 202 (30.1%) | |
Delay time-dependent procedures (min) | 90 (40–180) | 90 (40–330) | 95 (52.5–130.5) | .70 |
Oncological setting | .35 | |||
Procedures in non-oncologic patients | 586 (39.17%) | 334 (40.48%) | 248 (36.96%) | |
Procedures in oncologic patients | 642 (42.91%) | 342 (41.45%) | 300 (44.71%) | |
Oncologic treatments | 268 (17.91%) | 149 (18.06%) | 123 (18.33%) |
CT computed tomography, min minutes, US ultrasound